Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988 Oct;26(4):429-34.
doi: 10.1111/j.1365-2125.1988.tb03402.x.

Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol

Affiliations
Clinical Trial

Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol

R O Day et al. Br J Clin Pharmacol. 1988 Oct.

Abstract

1. 1-methyl xanthine (1-MX) is metabolized exclusively to 1-methyl uric acid (1-MU) by the enzyme xanthine oxidase. 2. The ratio of 1-MU to 1-MX in the urine, following a dose of 50 mg of 1-MX infused intravenously over 20 min, was used to measure the inhibition of xanthine oxidase induced by different doses of allopurinol. 3. Normal volunteers (n = 8) were given allopurinol 50, 100, 300 and 600 mg daily for 1 week each, in random order and 1 week separated each treatment. Inhibition of xanthine oxidase was assessed twice, on the last 2 days of each treatment week. 4. Steady-state oxipurinol concentrations increased linearly with increasing dose of allopurinol. 5. There was a hyperbolic relationship between the 1-MU/1-MX ratio and plasma oxipurinol concentrations, with an initial steep decline in the ratio which plateaued when plasma oxipurinol was around 4-6 mg l-1. This reduction in the ratio was quickly reversible upon cessation of allopurinol. 6. The 50% and 90% effective inhibitory oxipurinol concentrations, in relation to the 1-MU-/1-MX ratio were 1.4 +/- 0.46 and 4.08 +/- 2.03 mg l-1 respectively. 7. The concentration of oxipurinol required for almost complete inhibition of the enzyme was substantially less than those often observed in clinical practice.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Pharmacol. 1966 Jul;15(7):863-80 - PubMed
    1. Am J Med. 1964 Dec;37:839-61 - PubMed
    1. Biochem J. 1969 May;112(4):527-32 - PubMed
    1. Arch Biochem Biophys. 1972 Jun;150(2):585-99 - PubMed
    1. Adv Exp Med Biol. 1974;41:663-7 - PubMed

Publication types